False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients
Background: A small proportion of false rifampicin resistant results have previously been reported using GeneXpert MTB/RIF version G4 on sputum samples; however, this has not been investigated for urine samples in HIV-associated tuberculosis (TB). Objectives: We sought to determine the proportion of...
Saved in:
Main Authors: | Charlotte Schutz (Author), Amy Ward (Author), Rosie Burton (Author), Mark P. Nicol (Author), Liz Blumenthal (Author), Graeme Meintjes (Author), Andrew D. Kerkhoff (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis
by: Ruan Spies, et al.
Published: (2022) -
Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
by: Elise De Vos, et al.
Published: (2023) -
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
by: Dr. Gavin J Churchyard, PhD, et al.
Published: (2015) -
Utilization of GeneXpert MTB/RIF in the Southern Department of Haiti
by: T. Kedia, et al.
Published: (2015) -
Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020)